Illinois To Resume Use Of Johnson & Johnson COVID-19 Vaccine Immediately

The Illinois Department of Public Health will immediately resume the use of the Johnson & Johnson COVID-19 vaccine. Starting Saturday, the Johnson & Johnson vaccine will be offered at Chicago's vaccination site at Kennedy King College.

Video Transcript

SUZANNE LE MIGNOT: The Illinois Department of Public Health is going to resume the use of the Johnson & Johnson COVID-19 vaccine immediately. Starting today, the J&J vaccine will be offered at Chicago's vaccination site at Kennedy King College. A CDC panel gave the green light for the shots to continue with a warning.

The vaccine was paused 11 days ago. That decision came after reports of a rare kind of blood clot in patients who had the J&J shot. Researchers wanted to take a closer look at the connection.

The panel uncovered 15 cases, three deaths, mostly in women under the age of 50. The government decided the benefits of the vaccine still outweigh the risks of COVID-19. By resuming the shot, the panel determined we could see fewer than 50 additional clotting cases, but could prevent up to 1,400 deaths from COVID-19.

Next week, the Chicago Federation of Labor vaccination site, the Chicago State University's drivethrough site, Protect Chicago Homebound, and the city's vaccination bus program will all resume operations with the Johnson & Johnson vaccine.